Close

Form EFFECT XORTX Therapeutics Inc.

October 3, 2022 7:20 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: September 30, 2022
Accession Number: 0001104659-22-104261
Submission Type: POS AM
CIK: 0001729214
Company Name: XORTX Therapeutics Inc.
File Number: 333-267328


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings